For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Arris Pharmaceutical Corporation

USPTO Granted Patents = 11

Forward Citations = 389

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Charles R Johnson (4 out of 5 patents)

Derek Hudson (3 out of 11 patents)

Lutz B Giebel (3 out of 3 patents)

4. James M Clark (2 out of 9 patents)

5. David Chapman (2 out of 3 patents)

6. Kevin R Shoemaker (2 out of 7 patents)

7. Heinz W Gschwend (2 out of 2 patents)

8. Thomas E Jenkins (1 out of 61 patents)

9. Robert T Lum (1 out of 25 patents)

10. James T Palmer (1 out of 19 patents)

11. Robert L Warne (1 out of 8 patents)

12. Kathleen Okamoto (1 out of 2 patents)

13. Bradley A Katz (1 out of 6 patents)

14. David Rasnick (1 out of 4 patents)

15. Jeffrey Lee Klaus (1 out of 4 patents)

11 patents: Sort by Forward Citations

1. 5776718 - Reversible protease inhibitors (1998-07-07),

2. 5736357 - Cathespin O protease (1998-04-07),

3. 5703792 - Three dimensional measurement of molecular diversity (1997-12-30),

4. 5693515 - Metal complexed serine protease inhibitors (1997-12-02),

5. 5656660 - Compositions and methods for treating mast-cell mediated conditions (1997-08-12),

6. 5591646 - Method and apparatus for peptide synthesis and screening (1997-01-07),

7. 5585275 - Pilot apparatus for peptide synthesis and screening (1996-12-17),

8. 5576220 - Thin film HPMP matrix systems and methods for constructing and (1996-11-19),

9. 5567602 - Recombinant production of chymase (1996-10-22),

10. 5526281 - Machine-learning approach to modeling biological activity for molecular (1996-06-11),

11. 5525623 - Compositions and methods for the treatment of immunomediated (1996-06-11),

Arris Pharmaceutical Corporation is a biotechnology firm based in South San Francisco, California, focused on developing innovative therapies for patients with serious diseases. The company specializes in the discovery and advancement of novel drug candidates, leveraging cutting-edge research in areas such as oncology and neurology. Arris aims to address unmet medical needs through its commitment to scientific excellence and collaboration, striving to bring transformative treatments to market that improve patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

11 Patents

#98 in South San Francisco, CA

#6,532 in California

#27,490 in US

#51,714 in the World

South San Francisco, CA, United States of America

Arris Pharmaceutical Corporation

Forward Citations = 389

28 inventors:

Charles R Johnson (4 out of 5 patents)

Derek Hudson (3 out of 11 patents)

Lutz B Giebel (3 out of 3 patents)

4. James M Clark (2 out of 9 patents)

5. David Chapman (2 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…